Literature DB >> 18588360

Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.

Keming Gao1, Marcia L Verduin, David E Kemp, Bryan K Tolliver, Stephen J Ganocy, Omar Elhaj, Sarah Bilali, Kathleen T Brady, Robert L Findling, Joseph R Calabrese.   

Abstract

OBJECTIVE: To compare clinical variables in patients with rapid-cycling bipolar I or II disorder and a recent history of substance use disorder (SUD).
METHOD: Cross-sectional data from 2 studies of patients with rapid-cycling bipolar I disorder or rapid-cycling bipolar II disorder and a recent history of SUD were used to retrospectively assess the differences in clinical variables between the subtypes. The studies were conducted from November 1997 to February 2007 at University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio. Extensive clinical interview and the Mini-International Neuropsychiatric Interview were used to ascertain DSM-IV diagnoses of rapid-cycling bipolar disorder, SUDs, and other Axis I disorders and to collect clinical variables. The Addiction Severity Index (ASI), Global Assessment Scale (GAS), and the Medical Outcomes Study 36-Item Short-Form Health Survey were used to measure the severity of impairment at the initial assessment. One-way analysis of variance or chi(2) was used for significance tests. A Bonferroni adjustment was applied for multiple comparisons.
RESULTS: Of 245 patients with rapid-cycling bipolar disorder (rapid-cycling bipolar I disorder, N = 191; rapid-cycling bipolar II disorder, N = 54) and a recent history of SUD, the demographics were similar. A significantly higher rate of panic disorder was observed in patients with rapid-cycling bipolar I disorder than in those with rapid-cycling bipolar II disorder (odds ratio = 3.72, 95% CI = 1.66 to 8.32, p = .008). A significantly higher psychiatric composite score on the ASI was also found in patients with rapid-cycling bipolar I disorder than in those with rapid-cycling bipolar II disorder even after Bonferroni adjustment (p = .0007). There were no significant differences between the subtypes in the rates of previous hospitalization or suicide attempt, early childhood verbal, physical, or sexual abuse, lifetime substance abuse or dependence, the number of SUDs or mood episodes in the last 12 months, and total or other subscale scores on ASI and GAS.
CONCLUSION: Except for the significantly higher rate of comorbid panic disorder and higher psychiatric composite scores on the ASI in patients with rapid-cycling bipolar I disorder than in those with rapid-cycling bipolar II disorder, the other clinical variables were similar between the 2 groups.

Entities:  

Mesh:

Year:  2008        PMID: 18588360      PMCID: PMC4285700          DOI: 10.4088/jcp.v69n0703

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  41 in total

1.  Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders.

Authors:  L Tondo; R J Baldessarini; J Hennen; G Floris
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Andrew C Leon; David A Solomon; William Coryell; Jack D Maser; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2005-12

4.  Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry.

Authors:  K N Chengappa; J Levine; S Gershon; D J Kupfer
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

5.  Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.

Authors:  S L McElroy; L L Altshuler; T Suppes; P E Keck; M A Frye; K D Denicoff; W A Nolen; R W Kupka; G S Leverich; J R Rochussen; A J Rush; R M Post
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

6.  Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes.

Authors:  Giuseppe Maina; Umberto Albert; Laura Bellodi; Cristina Colombo; Carlo Faravelli; Palmiero Monteleone; Filippo Bogetto; Giovanni B Cassano; Mario Maj
Journal:  J Clin Psychiatry       Date:  2007-02       Impact factor: 4.384

7.  Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder.

Authors:  Dean F MacKinnon; Peter P Zandi; Jennifer Cooper; James B Potash; Sylvia G Simpson; Elliot Gershon; John Nurnberger; Theodore Reich; J Raymond DePaulo
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

8.  Perpetration of partner violence: effects of cocaine and alcohol dependence and posttraumatic stress disorder.

Authors:  Dominic J Parrott; David J Drobes; Michael E Saladin; Scott F Coffey; Bonnie S Dansky
Journal:  Addict Behav       Date:  2003-12       Impact factor: 3.913

9.  Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients.

Authors:  Ihsan M Salloum; Antoine Douaihy; Oliver K Ndimbie; Levent Kirisci
Journal:  J Addict Dis       Date:  2004

10.  Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample.

Authors:  Erika H Saunders; Laura J Scott; Melvin G McInnis; Margit Burmeister
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-01-05       Impact factor: 3.568

View more
  8 in total

1.  Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.

Authors:  K Gao; D E Kemp; C Conroy; S J Ganocy; R L Findling; J R Calabrese
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

2.  Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.

Authors:  Keming Gao; David E Kemp; Zuowei Wang; Stephen J Ganocy; Carla Conroy; Marry Beth Serrano; Martha Sajatovic; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

3.  A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder.

Authors:  Ranran Li; Renrong Wu; Jun Chen; David E Kemp; Ming Ren; Carla Conroy; Philip Chan; Mary Beth Serrano; Stephen J Ganocy; Joseph R Calabrese; Keming Gao
Journal:  Psychopharmacol Bull       Date:  2016-03-01

4.  A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.

Authors:  Keming Gao; Stephen J Ganocy; Carla Conroy; Brittany Brownrigg; Mary Beth Serrano; Joseph R Calabrese
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

5.  Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders.

Authors:  Keming Gao; Philip K Chan; Marcia L Verduin; David E Kemp; Bryan K Tolliver; Stephen J Ganocy; Sarah Bilali; Kathleen T Brady; Robert L Findling; Joseph R Calabrese
Journal:  Am J Addict       Date:  2010 Sep-Oct

6.  Designing the minimum data set of bipolar disorder: A basis for introducing the effective factors in managing, controlling, and monitoring the bipolar disorder.

Authors:  Khadijeh Moulaei; Kambiz Bahaadinbeigy; Shahrzad Mazhari
Journal:  J Educ Health Promot       Date:  2022-06-11

7.  Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder.

Authors:  Keming Gao; Bryan K Tolliver; David E Kemp; Marcia L Verduin; Stephen J Ganocy; Sarah Bilali; Kathleen T Brady; Seong S Shim; Robert L Findling; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2008-01-29       Impact factor: 4.839

8.  Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessment.

Authors:  Keming Gao; Bryan K Tolliver; David E Kemp; Stephen J Ganocy; Sarah Bilali; Kathleen L Brady; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2009-07       Impact factor: 4.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.